Saturday, July 25, 2026
Via News Knowledge File

Johnson & Johnson Services, Inc.

organization80% conf.·synced Jul 25, 2026

Uses biomarkers to advance drug development and personalized treatment approaches across oncology, immunology, and neuroscience

47
sourced metrics
1214
relationships
20
stated objectives
0
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Market Share
7.5percent
Jul 20, 2026source
Revenue
23743USD
Jul 15, 2026source
Eps
2.27USD
Jul 15, 2026source
Adjusted Net Earnings
6699USD
Jul 15, 2026source
Net Income
5537USD
Jul 15, 2026source
Free Cash Flow
6214USD
Jul 15, 2026source
Operational Sales Growth
5.6percent
Jul 15, 2026source
Adjusted Eps
2.77USD
Jul 15, 2026source
Adjusted Operational Sales Growth
5.7percent
Jul 15, 2026source
Earnings
4.7percent
Jul 15, 2026source
Reported Sales Growth
6.6percent
Jul 15, 2026source
Dividend Consecutive Increase Years
64years
Jul 13, 2026source
Dividend Per Share Quarterly
1.34USD
Jul 13, 2026source
Consecutive Dividend Increase Years
64years
Jul 5, 2026source
Stock Price
228USD
Jul 5, 2026source
Quarterly Dividend Per Share
1.34USD
Jul 5, 2026source
Dividend Increase Streak
64years
Jul 5, 2026source
Dividend Per Share Annualized
5.36USD
Jul 5, 2026source

Stated objectives

Achieve full-year 2025 sales of $93.5B-$93.9B, representing growth of 5.4%-5.9%

source
target: 93.5-93.9 billion USD stated

Improve adjusted pretax operating margin by approximately 300 basis points driven by cost savings and reduced acquired IPR&D costs

source
target: ~300 bps improvement stated

Achieve 2026 top-line growth of more than 5%, exceeding consensus of ~4.6%

source
target: >5% revenue growth stated

Achieve 2026 adjusted EPS approximately $0.05 above consensus of $11.39, implying ~$11.44

source
target: ~$11.44 adjusted EPS stated

Submit OTTAVA robotic surgical system for regulatory approval in the United States

source
target: Regulatory submission completed stated

Achieve higher operational sales growth in both Innovative Medicine and MedTech segments in 2026

source
by 2026-01-01 00:00:00stated

Improve MedTech growth and margins by completing the pending separation of the Orthopaedics franchise

source
stated

Strengthen presence in the neurological and psychiatric drug market via acquisition of Intra-Cellular Therapies

source
stated

Develop and deploy Ottava next-generation robotic surgery platform with AI-enabled ecosystem

source
stated

J&J expects sales growth in both Innovative Medicine and MedTech segments to be higher in 2026

source
target: higher than 2025 growth rates by 2026-01-01 00:00:00stated

Relationship graph · 1214 connections

Developed by
504
Competes with
128
subsidiary of
75
Covered by
71
Employs
59
Owns
56
acquired by
51
regulates
36

Where sources disagree

We surface conflicts between sources rather than hiding them.

value conflictunresolved

Free cash flow values differ by ~440x (8700 vs 19.7 USD) across only 1.5 years. While financial metrics can vary, this extreme divergence suggests a data quality issue—likely different calculation methods, unit mismatches (one possibly in millions while stated in dollars, or vice versa), or an extraction/measurement error rather than legitimate business performance change.

value conflictunresolved

Two different EPS values (2.29 USD vs 2.14 USD) are recorded for the same entity with no period specified. While EPS naturally varies across reporting periods, both facts show 'Period: N/A', which is anomalous. If both represent the entity's 'current' or 'latest' EPS at their respective observation dates, the discrepancy without period clarity suggests either: (1) data quality issues, (2) different calculation methodologies, or (3) missing period information that would explain the difference. The ~3.5 month gap between observations makes a legitimate period change plausible, but this cannot be confirmed without period data.

value conflictunresolved

Same entity and attribute (eps) have two significantly different values (2.27 USD vs 2.86 USD, ~26% difference). Both have Period: N/A, indicating they should represent the same reporting period. One has an observation timestamp (2026-07-15), the other has none, suggesting potential data source or timing misalignment. This represents a material conflict in financial data.

value conflictunresolved

Both facts represent EPS (earnings per share) for the same entity with significantly different values: 2.27 USD vs 11.55 USD (~5.1x difference). This is a substantial numerical discrepancy for a critical financial metric. The contradiction is weakened slightly by: (1) missing observation date on Fact B, (2) both facts missing explicit period information (N/A), which could indicate different reporting periods, calculation methods (basic vs diluted), or data sources. However, the magnitude of difference suggests a genuine conflict that requires investigation.

value conflictunresolved

The same entity has two significantly different EPS values: 2.27 USD (observed 2026-07-15) vs 12.40 USD (no observation date). A 5.5x difference in earnings per share is material. The contradiction is clear, though both facts lack period specification, and Fact B lacks a timestamp, which leaves some ambiguity about whether these represent different measurement contexts or methodologies.

value conflictunresolved

Both facts reference the same entity and attribute (eps) but report substantially different values (2.27 USD vs 11.54 USD, a 5x difference). The absence of period information for both facts, combined with one having an observation timestamp (2026-07-15) and the other having none, suggests these may refer to different fiscal periods or data sources. Without explicit period identifiers, having two unreconciled EPS values for the same entity indicates a data quality issue that should be investigated.

value conflictunresolved

The EPS values differ significantly (2.27 USD vs ~11.44 USD, approximately 5:1 ratio). However, the contradiction confidence is moderate because FACT B lacks period information. If FACT A represents quarterly EPS and FACT B represents annual/TTM (trailing twelve months) EPS, they would not contradict—they'd be different aggregation levels. If both represent the same period and measurement type (e.g., both Q2 2026 or both TTM), this is a clear value conflict. The missing observation date and period for FACT B introduces ambiguity about whether these should represent identical values.

value conflictunresolved

Same attribute (eps) for the same entity shows significantly different values: 2.29 USD vs ~11.44 USD (~5x difference). Both facts lack period information, preventing determination of whether these represent different time periods. Fact A is timestamped (2026-07-15), while Fact B has no timestamp. The large magnitude of the discrepancy suggests either data quality issues, different reporting bases (e.g., diluted vs. basic EPS), or data from different periods that should be clarified.

value conflictunresolved

The EPS value for Johnson & Johnson Services, Inc. shows a significant discrepancy (2.29 USD vs 11.54 USD, ~80% decrease). Observed on different dates (2026-07-15 vs 2026-03-03), these values cannot both represent the same reporting period. The critical issue is that both facts have 'Period: N/A', which suggests they may be claiming to represent current/general EPS values rather than specific quarterly or annual periods. If so, the entity cannot legitimately have two different current EPS values. If these are different reporting periods (Q1 vs Q2 2026), that would be normal time-series variation and not contradictory—but the missing period metadata creates ambiguity.

value conflictunresolved

The same entity has two significantly different EPS values (2.29 USD vs 11.54 USD, a 5x difference). Without explicit period information for either fact, these cannot be reconciled as different reporting periods. The values are too divergent to be explained by rounding or minor data variance. Fact A was observed on 2026-07-15, while Fact B has no observation timestamp, suggesting potential data quality issues or sources reporting different metrics under the same attribute name.

value conflictunresolved

Both facts report the adjusted_net_earnings attribute for the same entity (Johnson & Johnson Services, Inc.) at the same observation timestamp (2026-07-15 00:00:00), but with different values: 6699 USD vs 7081 USD. The difference of 382 USD (~5.7%) represents a material discrepancy that cannot be reconciled without additional context (such as different data sources, rounding, or revisions).

value conflictunresolved

Same entity (Johnson & Johnson Services, Inc.) has two different adjusted_eps values (2.90 USD vs 2.77 USD) recorded for the identical observation timestamp (2026-07-15). This is a direct value conflict—adjusted EPS cannot simultaneously be both 2.90 and 2.77 for the same company on the same date.

value conflictunresolved

Same entity (Johnson & Johnson Services, Inc.) reports two significantly different EPS values (2.29 USD vs 12.40 USD) without clear temporal differentiation. Both facts lack period information, making it unclear if they represent the same reporting period. Fact A has an observation timestamp (2026-07-15) while Fact B has none, suggesting potential data quality or source issues. The 5.4x value difference is substantial for a key financial metric.

value conflictunresolved

Same entity and attribute (EPS) but with significantly different values: 2.29 USD vs 11.55 USD. Fact A has an observation timestamp (2026-07-15) while Fact B has no timestamp. Without period information or source metadata, it's unclear if these represent different time periods, data sources, or methodologies (adjusted vs unadjusted, diluted vs basic). The 5x difference is substantial and cannot be explained by minor calculation variations.

value conflictunresolved

The two facts assert dramatically different values for the same attribute (free_cash_flow) on the same entity. Fact A reports $8,700 USD while Fact B reports $20 billion USD—a difference of approximately 2.3 million times. For a company like Johnson & Johnson with annual revenues exceeding $90 billion, the $8,700 figure is implausibly low and appears to be either corrupted data, missing unit conversion, or a measurement error. Fact B ($20 billion) is consistent with the financial scale of a Fortune 500 pharmaceutical company.

value conflictunresolved

Same attribute (eps) has two significantly different values for the same entity: 2.29 USD (Fact A, observed 2026-07-15) vs 2.86 USD (Fact B, no observation date). The 20% variance (0.57 USD delta) is material. Both entries lack period information (N/A), making it unclear whether these represent different reporting periods or a data quality issue. Fact A's timestamp suggests it's more recent, but Fact B's missing observation date prevents determining which value is current or authoritative.

value conflictunresolved

Fact A reports 8,700 USD in free cash flow while Fact B reports 18.54 billion USD — a ~2.13 million-fold difference for the same attribute. For an entity like Johnson & Johnson Services, Inc., both values are questionable (8.7K is implausibly low), but they cannot both be accurate for the same period. The timing discrepancy (Fact A has observation timestamp 2026-07-15, Fact B has none) suggests possible different periods or data sources, but without period clarity, this represents a material value conflict.

value conflictunresolved

Fact A reports free_cash_flow of 8,700 USD while Fact B reports 35.5 billion USD for the same entity. These values differ by a factor of approximately 4 million. Both claim to measure the same attribute (free_cash_flow) for Johnson & Johnson Services, Inc., with no period specification to disambiguate them. One value is almost certainly incorrect or represents a data quality issue (e.g., missing scaling factors, unit conversion error, or corrupted value).

value conflictunresolved

Same entity (Johnson & Johnson Services, Inc.), same attribute (free_cash_flow), same observation timestamp (2026-07-15 00:00:00), but conflicting values: 8700 USD vs 6214 USD. This represents a ~29% discrepancy and suggests either data from different sources, calculation method differences, or a data quality issue.

This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →